Evaluation of the Possible Effect of Inspiratory Muscle Training on Inflammation Markers and Oxidative Stress in Childhood Asthma
NCT ID: NCT05296707
Last Updated: 2024-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
105 participants
INTERVENTIONAL
2019-03-01
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study included asthma patient; 35 routine medication, 35 drug therapy and inspiratory muscle training (IMT), and 35 healthy total 105 children aged 8-17 years. Demographic information and hemogram values were recorded. Functional capacity was evaluated with the 6-minute walking test, quality of life PedsQL, respiratory muscle strength oral pressure measuring device, respiratory function test, dyspnea severity with Modified Borg Scale. C-Reactive Protein (CRP), Periostin, Transforming Growth Factor-βeta (TGF-β), Total Antioxidant Status (TAS), Total Oxidant Status (TOS), Oxidative Stress Index (OSI) were analyzed. IMT was given with a Threshold IMT device for 7 days/6 weeks at 30% of maximal inspiratory pressure, and then a second evaluation was made.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Expiratory Muscle Training in Children With Asthma: A Randomised Controlled Trial
NCT07169071
IMT in Asthma: Activity, Coping, Self-Management
NCT07320066
Dynamic Respiratory Muscle Strength and Endurance in Childhood Asthma
NCT06053905
Coupled Inspiratory and Expiratory Muscle Training in Children With Bronchial Asthma
NCT05212558
The Impact of Breath Exercises by Telemedicine in Patients Aged 8-18 Years With a Diagnosis of Asthma
NCT05749237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inspiratory muscle training group
Threshold IMT was given this group. Applied for 7 days 6 weeks.
Inspiratory muscle training
The MIP/MEP value of the group that will receive inspiratory muscle training was determined and Threshold IMT training was given with 30%.
In the training, the subjects were asked to sit in a relaxed position with their upper chest and shoulders relaxed.
After the nose clip was attached, the children were asked to inhale and exhale by tightly closing the mouthpiece of the instrument with their lips.
A 30-minute training session was carried out for 6 weeks, with 10-15 repetitive breathing apparatus and 5-10 seconds rest breaks every day.
Used routine medicine
After the first evaluation was made, a second evaluation was made after 6 weeks of follow-up.
Used routine medicine group
Followed 6 weeks
Used routine medicine
After the first evaluation was made, a second evaluation was made after 6 weeks of follow-up.
Control Group
Health children
Control group
A healthy child compatible with the age and sex of the patient group was evaluated once.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inspiratory muscle training
The MIP/MEP value of the group that will receive inspiratory muscle training was determined and Threshold IMT training was given with 30%.
In the training, the subjects were asked to sit in a relaxed position with their upper chest and shoulders relaxed.
After the nose clip was attached, the children were asked to inhale and exhale by tightly closing the mouthpiece of the instrument with their lips.
A 30-minute training session was carried out for 6 weeks, with 10-15 repetitive breathing apparatus and 5-10 seconds rest breaks every day.
Used routine medicine
After the first evaluation was made, a second evaluation was made after 6 weeks of follow-up.
Control group
A healthy child compatible with the age and sex of the patient group was evaluated once.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 8-17,
* No asthma attack,
* Cooperating with the study,
* Without cerebral palsy, mental retardation or any other major neurological diagnosis,
* Agreeing to participate in the study,
* Cases whose medication has not been changed for at least three weeks.
Exclusion Criteria
* Having advanced postural alignment problem,
* Having mental problems,
* Having neuromuscular disease,
* Making changes in the medications used in the last three weeks,
* Presence of inflammatory diseases such as juvenile idiopathic arthritis.
8 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mustafa Kemal University
OTHER
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ozden Gokcek
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University
Izmir, Karsıyaka, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gokcek O, Yurdalan U, Tugay BU, El C, Dogan S. Evaluation of the possible effect of inspiratory muscle training on inflammation markers and oxidative stress in childhood asthma. Eur J Pediatr. 2023 Aug;182(8):3713-3722. doi: 10.1007/s00431-023-05047-4. Epub 2023 Jun 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.